Loracarbef


DB00447



General information:


Withdrawn ID: DB00447
Canonical SMILES:
Standard InChI:
Standard InChIKey:
ATC class(es): J01DC08
Molecular Formula: C16H16ClN3O4
Molweight: 349.769



Withdrawal information:


Withdrawn due to drug safety reasons:No
First approved: 1991
First withdrawn: 2006
Last withdrawn: 2006



Side-effects:

Total reported cases (submitted by medical professionals) with Loracarbef as primary suspect: 21


Reported final outcomes:
Hospitalization (initial or prolonged): 12
Death: 1


Reported side-effects:

Side-effect Case number
Drug hypersensitivity8
RASH3
Tubulointerstitial nephritis2
ARTHRALGIA2
DYSPNOEA2
NEPHRITIS INTERSTITIAL2
CHEST PAIN1
HAEMATURIA1
GLYCOSURIA1
ERYTHEMA MULTIFORME1
DYSTONIA1
DRUG ERUPTION1
DIZZINESS1
DIFFICULTY IN WALKING1
DERMATITIS ALLERGIC1
CONVULSION1
CHILLS1
HYPERTENSION1
CHEST DISCOMFORT1
BONE SWELLING1
BONE MARROW DEPRESSION1
BLOOD CREATINE PHOSPHOKINASE INCREASED1
ASTHENIA1
ANURIA1
ANTIBODY TEST POSITIVE1
ANAPHYLACTIC SHOCK1
ABASIA1
PARKINSONISM1
UNEVALUABLE EVENT1
TOOTHACHE1
TONGUE DISORDER1
THROMBOCYTOPENIA1
SWELLING FACE1
Shock1
RENAL FAILURE1
RASH MACULAR1
PRURITUS1
PNEUMONIA MYCOPLASMAL1
PETECHIAE1
HAEMODIALYSIS1
PAIN IN EXTREMITY1
OEDEMA PERIPHERAL1
OBSTRUCTIVE AIRWAYS DISORDER1
NAUSEA1
MYOGLOBIN BLOOD INCREASED1
MUSCLE RIGIDITY1
Loss of consciousness1
LEUKOCYTOSIS1
HYPOAESTHESIA FACIAL1
WHEEZING1
HYPERSENSITIVITY1





Toxicity information:

Toxicity type: N/A



External links:

ChEBML: CHEMBL1013
DrugBank: DB00447